leisure time -WSS

leisure time

author：focus 2025-09-30 23:06:26 - browse：76275

David Liu and Jonathan Wosen on the STAT Summit stage. — David Liu (left) with reporter Jonathan Wosen at the 2022 STAT Summit. STAT

David Liu, the Broad Institute biochemist behind two powerful forms of genome editing, is launching a company focused on delivering gene-editing machinery to precise cells and tissues in the body, STAT has learned.

The company, known as Nvelop, already raised a $100 million seed round last year, according to PitchBook. It is being run by Jeff Walsh, a former top executive at Bluebird Bio, and it recently recruited Bluebird’s head of research, Melissa Bonner, according to two people with knowledge of the situation. Bluebird had not previously disclosed Bonner’s departure.

Nvelop is the latest entry in a race among top labs and deep-pocketed investors to solve a delivery problem that has stunted efforts to turn CRISPR and other genetic tools into disease-altering medicines. The goal is to develop a cargo system precise enough to deliver CRISPR or other machinery to cells of a researchers’ choosing, particularly tissues that have been hard to reach with previous approaches, like neurons, muscle, and blood stem cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

leisure time

knowledge

WSS

Novo Nordisk testing Wegovy against alcohol

WuXi Biologics beefs up its lobbying operation

Patient advocates debate FDA's accelerated approval process

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

ALS treatment from Biogen, Ionis fails in study

WuXi Biologics execs register to lobby as Congress comes for the company

explore

leisure time

hotspot

In Memoriam: Notable people who died in 2023

Hottest summer in 2,000 years puts focus on extreme heat, health

Malaria cases in Florida and Texas: Here’s what you need to know

Ripples from Flovent's discontinuation is killing children with asthma

In age of alternative facts, a scholarly course on calling out crap

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Drug repurposing or repositioning? The language matters

STAT series 'Denied by AI' wins major journalism prizes

Activists slam private health insurers over coverage restrictions

HHS suspends federal funding for EcoHealth Alliance

focus

Food as medicine: Medically tailored meals may get standardized

Scientists boost immune system in aging mice by making it youthful

Boston hospital trains restaurant workers on naloxone for overdoses

Study says nonprofit hospitals fall short in charity care spending

STAT series 'Denied by AI' wins major journalism prizes

Supreme Court to hear if Covid misinformation is protected speech

leisure time

leisure time

knowledge

entertainment